Empowering Consumers as Contributors for Health Product Safety: Lessons from the Philippines
Tóm tắt
Empowering consumers to contribute to adverse drug reaction reporting seems a sensible innovation, particularly when traditional reports emanating from healthcare professionals are neither increasing nor improving. This work, inspired by an EU-FP7-funded project, describes an attempt by the Philippines to introduce a consumer reporting system through education and an online platform for reporting, and the lessons that were captured in the process. While participating consumers did not contribute to the adverse drug reporting process in the traditional sense as originally expected, the reports received by the drug regulatory agency revealed consumers’ concerns regarding health product legitimacy, quality and market claims, as well as the lack of available and accessible information. These reports led regulators to take action. Initial insights on consumer behavior are proposed for regulators and industry to consider in greater depth and how this may impact on consumers providing valued information that will promote other aspects of product safety.
Tài liệu tham khảo
Monitoring Medicines. EU-FP7 Monitoring Medicines project. Available at: http://www.monitoringmedicines.org. Accessed 9 Feb 2015.
Raine JM. Drug safety: reporting systems for the general public. BMJ. 2012;345:e4916.
Christensen CM, Grossman JH, Hwang J. Integrating to make it happen. In: Christensen CM, Grossman JH, Hwang J, editors. The innovator’s prescription: a disruptive solution for health care. New York: McGraw-Hill; 2009. p. 183–220.
Hartigan-Go K. Challenges of drug risk communications in the Philippines. Drug Saf. 2012;35(11):995–1004.
Van Hunsel F, Harmark L, Pal S, Olsson S, Van Grootheest K. Experiences with adverse drug reaction reporting by patients. Drug Saf. 2012;35(1):45–60.
Hsiao W, Reich MR, Takemi T. Regulations. In: Roberts MJ, Hsiao W, Berman P, Reich MR, editors. Getting health reform right: a guide to improving performance and equity. Oxford: Oxford University Press; 2003. p. 247–80.
Bennis W, Goleman D, Biederman PW. Creating a culture of candor. In: Bennis W, Goleman D, O’Toole J, editors. Transparency: how leaders create a culture of candor. San Francisco (CA): Jossey-Bass; 2008. p. 1–43.
Republic of the Philippines Food and Drug Administration. FDA Advisory No. 2014-058. Warning on fraudulent sales strategies employed by websites involved in buy and sell of health products. Available at: http://www.fda.gov.ph/advisories/312-others/177689-fda-advisory-no-2014-058. Accessed 9 Feb 2015.
Republic of the Philippines Food and Drug Administration. FDA Advisory No. 2014-041. Deceptive on-line sale and marketing of inner power stem cell booster. Available at: http://www.fda.gov.ph/advisories/pharmaceutical/161953-fda-advisory-no-2014-041. Accessed 9 Feb 2015.
Republic of the Philippines Food and Drug Administration. FDA Advisory No. 2014-042. Public warning against advertisement, promotion, offer for sale and use of “Bangkok Pills”. Available at: http://www.fda.gov.ph/advisories/pharmaceutical/161954-fda-advisory-no-2014-042. Accessed 9 Feb 2015.
Republic of the Philippines Food and Drug Administration. FDA Advisory No. 2014-051. Public warning against false advertisement, promotion, offer for sale and use of “Optrimax Plum”. Available at: http://www.fda.gov.ph/advisories/food/169794-fda-advisory-no-2014-051. Accessed 9 Feb 2015.
Hopkins DM, Kontnik LT, Turnage MT. Pharmaceuticals. In: Hopkins DM, Kontnik LT, Turnage MT, editors. Counterfeiting exposed. Hoboken (NJ): Wiley; 2003. p. 69–93.
McAdams T, Neslund N, Zucker KD. Business, torts and product liability. In: McAdams T, Neslund N, Zucker KD, editors. Law, business and society. 10th ed. New York: McGraw-Hill; 2012. p. 282–330.
Rifkin E, Bouwer E. The physician’s and patient’s perspectives. In: Rifkin E, Bouwer E, editors. The illusion of certainty (health benefits and risks). Berlin: Springer; 2007. p. 167–87.
Frank RG. Behavioral economics and health economics. In: Diamond P, Vartiainen H, editors. Behavioral economics and its applications. Princeton: Princeton University Press; 2007. p. 195–234.
Mowen JC, Minor M. Information processing I: involvement and perception. In: Mowen JC, Minor M, editors. Consumer behavior. 5th ed. USA: Prentice Hall; 2000. p. 64–6.
Van Hunsel F, ten Berge E, Borgsteede SD, et al. What motivates patients to report ADR? Ann Pharmacother. 2010;44:936–7.
East R, Wright M, Vanhuele M. Consumer behaviour: applications in marketing. Thousand Oaks (CA): Sage Publishing; 2008. p. 166–90.
Republic of Philippines Food and Drug Administration. FDA Advisory No. 2014-057. Patient counselling by physicians and pharmacists. Available at: http://www.fda.gov.ph/attachments/article/177652/FA2014-057%20-%20Patient%20Counselling%20by%20the%20Physician%20and%20Pharmacists.pdf. Accessed 9 Feb 2015.
Van Hunsel F, van der Welle C, Passier A, et al. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. Eur J Clin Pharmacol. 2010. Available at: http://www.lareb.nl/LarebCorporateWebsite/media/Publicaties/2010_3_EJCP_Motives_reporting_ADRs_patient-reporters_Netherlands.pdf. Accessed 20 Oct 2014.
Van Hunsel F, van Puijenbroek E, de Jong-van den Berg LTW, et al. Media attention and influence on reporting odds ratio in disproportionality analysis: an example of patient reporting of statins. Pharmacoepidemiol Drug Saf. 2010;19:26–32.
Kotler P, Roberto EL. The nature and role of social campaigns to change public behavior. In: Social marketing. New York: Free Press, Macmillan Inc.; 1989. p. 3–23.
De Savigny D, Adam T, editors. Systems thinking for health systems strengthening. World Health Organization; 2009. p. 32.
Goldfarb A, Ho TH, Amaldoss W, et al. Behavioral models of managerial decision-making. Mark Lett. 2012;23:405–21.